Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
Why Did Planned Parenthood Close Tyler Location?
Tech & Innovation Why Did Planned Parenthood Close Tyler Location?

In Tyler, Texas, the shutdown of Planned Parenthood as of July 17 has prompted discussions about healthcare access and legislative impacts. This transition, confirmed through a notice and online communication, marks a strategic pivot for the organization towards telehealth services, facilitated by

Open-Source AI Rivals Commercial Models in Medical Scan Reporting
Tech & Innovation Open-Source AI Rivals Commercial Models in Medical Scan Reporting

A groundbreaking study from the University of Colorado Anschutz Medical Campus has emerged, focusing on the application of open-source artificial intelligence tools in the medical scan reporting domain. It highlights a significant development: these tools can perform on par with costly commercial

J&J Advances Immunology with Pathway-Centric Drug Strategy
Research & Development J&J Advances Immunology with Pathway-Centric Drug Strategy

Johnson & Johnson (J&J) is making significant strides in immunology drug development by embracing a pathway-centric approach to redefining autoimmune disease treatment under the leadership of Dr. Katie Abouzahr. This strategy diverges from traditional methods by prioritizing a multi-indication

Gene Therapy Offers New Hope for Rett Syndrome Treatment
Research & Development Gene Therapy Offers New Hope for Rett Syndrome Treatment

Rett syndrome, a rare genetic disorder primarily affecting young girls, represents a profound medical challenge due to its debilitating symptoms and lack of a definitive cure. Originating from mutations in the MECP2 gene situated on the X chromosome, this condition leads to a deficiency in a

Universal Cancer Vaccine Breakthrough Boosts Immune System
Research & Development Universal Cancer Vaccine Breakthrough Boosts Immune System

Ivan Kairatov is a renowned Biopharma expert with a wealth of experience in research and development, particularly at the intersection of technology and innovation in the field. Today, he shares insights into the groundbreaking research conducted at the University of Florida on developing a

Advancing Nanotechnology: New Standard Reference Materials Unveiled
Tech & Innovation Advancing Nanotechnology: New Standard Reference Materials Unveiled

In the dynamic domain of nanotechnology, the utilization of nanomaterials is essential for propelling advancements across numerous industries, including electronics, medicine, and environmental science. The caliber of reference materials significantly impacts these developments, as these materials

How Do Evolving Racial Categories Impact Cancer Data Collection?
Research & Development How Do Evolving Racial Categories Impact Cancer Data Collection?

In the rapidly evolving field of cancer epidemiology, understanding how race and ethnicity interact with cancer incidence and mortality is crucial. Ivan Kairatov, a biopharma expert with a strong background in research and development, sheds light on the implications of changing race data

Is Sprout Health the Future of Telehealth for Longevity?
Tech & Innovation Is Sprout Health the Future of Telehealth for Longevity?

In the rapidly evolving landscape of digital health, finding innovative solutions to address aging and enhance energy has become a major focus. As 2025 unfolds, Sprout Health's NAD+ (nicotinamide adenine dinucleotide) Injections have emerged as a groundbreaking telehealth solution. This

Measuring Tumor Forces: New Insights for Brain Cancer Treatment
Research & Development Measuring Tumor Forces: New Insights for Brain Cancer Treatment

The hidden might of tumors could hold the key to transforming brain cancer treatment. Aided by the latest research, scientists and healthcare professionals uncover how the physical forces exerted by cancerous growths could pave the way for novel therapeutic strategies. The Bridge Between Physics

Will Kane Propel Uniquity Bio to Immunology Leadership?
Research & Development Will Kane Propel Uniquity Bio to Immunology Leadership?

In a groundbreaking move, Uniquity Bio has appointed industry veteran Will Kane as its new President and CEO amid its ambitious drive towards late-stage drug development. With over 30 years in the biopharmaceutical industry, Kane brings a wealth of experience from his previous executive roles at

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later